Record Demand! Exato Technologies IPO GMP Today Shoots Up 125% as Issue Gets 947x Subscription — Allotment Today
Exato Technologies IPO GMP today has grabbed trader and investor attention, as the SME issue shows a sharp rise of 125% in the grey market premium ahead of its listing. The IPO aims to raise ₹37.45 crore with a price band of ₹133–₹140 per share & the allotment statuts will be out today.
This detailed analysis covers IPO dates, GMP trend, expert commentary, whether investors should apply, allotment strategy, and FAQs.
What Are the Key Exato Technologies IPO Dates?
| Event | Date |
|---|---|
| IPO Opening Date | November 28, 2025 |
| IPO Closing Date | December 2, 2025 |
| Basis of Allotment | December 3, 2025 (Tentative) |
| Refunds Initiation | December 4, 2025 |
| Demat Transfer | December 5, 2025 |
| Expected Listing | December 6, 2025 |
| Issue Size | ₹37.45 crore |
| Price Band | ₹133 – ₹140 |
| Market Lot | 2,000 shares |
What Is Exato Technologies IPO GMP Today & GMP Trend?
Below is the updated Exato Technologies IPO GMP today & day-wise GMP trend based on market observers:
Exato Technologies IPO GMP Trend Table
| Date | IPO GMP | GMP Trend | Approx. Gain % |
|---|---|---|---|
| 3 Dec | ₹175 | IPO GMP Up | 125% |
| 2 Dec | ₹150 | IPO GMP Up | 107.14% |
| 1 Dec | ₹131 | IPO GMP Up | 93.57% |
| 29 Nov | ₹120 | IPO GMP Up | 85.71% |
| 28 Nov | ₹116 | IPO GMP Up | 82.86% |
| 27 Nov | ₹95 | IPO GMP Up | 67.86% |
Interpretation:
With the Exato Technologies IPO GMP Today at ₹175, the premium has witnessed a strong uptrend & the expected listing price could be around ₹315, implying nearly 125% potential upside over the upper price band.
What Are Analysts and Experts Saying About the Exato Technologies IPO?
Market analysts highlight the following points:
- Strong GMP momentum indicates healthy listing expectations.
- ₹37.45 crore issue size makes it a relatively small offering, which often leads to higher listing volatility.
- The company’s digital transformation and IT automation business is well-positioned for India’s expanding tech spend.
- Revenue consistency and improving margins are positives, though SME IPOs carry higher risk due to limited liquidity.
- Experts suggest that with the current GMP trend, listing gains look increasingly likely, but investors must assess risk appetite.
Should You Apply for the Exato Technologies IPO?
A practical view:
✔ Apply For Listing Gains If:
- You aim for short-term gains based on strong GMP.
- You understand SME IPO volatility.
- You are comfortable with subscribing in large lots (2,000 shares).
✔ Apply For Long-Term Only If:
- You believe in the digital transformation industry’s growth.
- You can hold through post-listing volatility.
❌ Avoid If:
- You prefer large-cap stability.
- High listing-day volatility does not suit your risk profile.
Verdict:
Given the rising Exato Technologies IPO GMP Today, the listing sentiment appears strong. Aggressive investors may consider applying for listing gains.
How Can You Apply for the Exato Technologies IPO?
You can apply through:
- Net Banking ASBA – via your bank’s IPO section.
- UPI-based Applications – using broker apps like Zerodha, Angel, Groww, ICICI Direct, etc.
- Choose your lot size, enter UPI ID, approve mandate, and submit.
Ensure your UPI mandate is approved before the final cut-off time.
Frequently Asked Questions (FAQs) on Exato Technologies IPO GMP Today
1. What is the Exato Technologies IPO issue size?
The total issue size of Exato Technologies IPO is ₹37.45 crore.
2. What is the market lot for this IPO?
The lot size is 2,000 shares, making the minimum investment around ₹2.66 lakh.
3. What is Exato Technologies IPO GMP Today?
The current GMP is ₹175, indicating strong listing expectations.
4. Is Exato Technologies an SME IPO?
Yes, it is listed under the SME segment.
5. What is the expected listing gain?
Based on GMP, a 125% listing gain is currently projected.
Click Here to know more market & IPO related news and updates.
Disclaimer: The views and investment insights provided here are based on publicly available information and do not constitute financial advice. Readers are advised to conduct their own research or consult certified financial experts before making investment decisions.
